We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 07 APRIL 2009
FTC "No Action" On Pharmaceutical Patent Settlements Does Not Spell End To Reverse Payments Dispute

Jones Day
Contributor

Jones Day
Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....
View firm profileEarlier this month, Federal Trade Commission staff sent letters to four pharmaceutical companies disclosing its current intention not to challenge pharmaceutical litigation settlement agreements.
United StatesAntitrust/Competition Law










